Table 4.
Table shows the odds ratio of reactivity against different cit-Fib peptides and genetic risk allels in RA (HLA-DR SE and PTPN22 risk allele)
Cit-Fib α 35 | Cit-Fib α 216,218 | Cit-Fib α 263,271 | Cit-Fib α 425,426 | Cit-Fib protein | ||||||
---|---|---|---|---|---|---|---|---|---|---|
OR (95% CI) | P value | OR (95% CI) | P value | OR (95% CI) | P value | OR (95% CI) | P value | OR (95% CI) | P value | |
SE | 1.6 (0.8–3.2) | 0.21 | 0.7 (0.3–1.4) | 0.31 | 1.3 (0.7–2.6) | 0.39 | 1.4 (0.7–2.9) | 0.37 | 2.1 (1.2–3.5) | 0.008 |
PTPN22 | 1.8 (1–3.1) | 0.04 | 0.6 (0.3–1.2) | 0.14 | 2.0 (1.1–3.4) | 0.02 | 1.6 (0.9–2.8) | 0.14 | 2.1 (1.3–3.5) | 0.002 |
cit-Fib citrullinated fibrinogen, RA rheumatoid arthritis, SE shared epitope